# Cerenovus, Inc. (manufacturer, Miami, FL): 5 new FDA device listings, incl. device, neurovascular embolization

**Score:** 95/100

| Field | Value |
|---|---|
| Establishment | Cerenovus, Inc. |
| Role | Manufacturer |
| Establishment types | Develop Specifications But Do Not Manufacture At This Facility; Manufacture Device in the United States for Export Only |
| Location | Miami, FL, US |
| New listings | 5 |
| Devices | Device, Neurovascular Embolization; Device, Vascular, For Promoting Embolization; Catheter, Thrombus Retriever; Catheter, Percutaneous, Neurovasculature; Neurovascular Liquid Embolic Agent |
| Product codes | HCG, KRD, NRY, QJP, SGU |
| Device classes | Class II, Class III |
| Medical specialties | Neurology, Cardiovascular |
| Brand names | MICRUSFRAME, DELTAFILL, DELTAXSFT, GALAXY G3, GALAXY G3 XSFT, GALAXY G3 Mini Microcoil Delivery System; CEREGLIDE 57 Intermediate Catheter; TRUFILL n-BCA Liquid Embolic System |
| First new listing | 2026-08-26 |
| Latest new listing | 2026-09-30 |
| FDA registration number | 3007628272 |
| Registration expires | 2026-12-31 |

## Why this score
- Brings its own devices to market: buys manufacturing, sterilization and QMS help.
- Class II or III devices: QMS and regulatory demands.
- Several new listings at once.
- U.S. establishment.
- Listed in the last 45 days.

Source: openFDA device registration and listing endpoint (U.S. Food and Drug Administration) (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm). Last refreshed: 2026-10-28T20:51:27.468Z.
From the openFDA device registration and listing data, refreshed weekly. A listing shows a device an establishment says it makes or handles for the U.S. market; it is not FDA clearance or approval. Contact persons and street addresses are not stored. Verify in the FDA Establishment Registration and Device Listing database.